This inventor holds 5 USPTO granted patents and 12 published patent applications and 1 EPO patent. Top assignee: Translate Bio, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: The Innovative Contributions of Saswata Karmakar
Introduction
Saswata Karmakar is a notable inventor based in Waltham, MA, who has made significant contributions to the field of biotechnology. With a total of three patents to his name, Karmakar's work focuses on advancing the delivery of nucleic acids and proteins, which are crucial for various medical applications.
Latest Patents
One of Karmakar's latest patents involves the development of vitamin cationic lipids. These cationic lipids comprise a vitamin substructure and an ionizable nitrogen-containing group. They are designed to enhance the delivery and expression of mRNA and encoded proteins, making them valuable for treating diseases associated with protein deficiencies. Another significant patent is centered on compositions and methods for facilitating the delivery of synthetic nucleic acids to cells. This innovation includes the use of targeting moiety-conjugated oligonucleotides, such as N-acetylgalactosamine (GalNAc)-conjugated oligonucleotides, to improve the delivery of nucleic acids into cells or tissues.
Career Highlights
Karmakar is currently employed at Translate Bio, Inc., where he continues to push the boundaries of biotechnological research. His work is instrumental in developing new methods for gene therapy and other therapeutic applications.
Collaborations
Karmakar collaborates with talented individuals in his field, including Balkrishen Bhat and Jia Tay, who contribute to the innovative environment at Translate Bio, Inc.
Conclusion
Saswata Karmakar's contributions to biotechnology through his patents and collaborative efforts highlight his role as a leading inventor in the field. His work promises to have a lasting impact on medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile